Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine

Thumbnail
Date
2011
Author
Erguven, Mine
Bilir, Ayhan
Yazihan, Nuray
Ermis, Ezgi
Sabanci, Akin
Aktas, Esin
Aras, Yavuz
Alpman, Vehbi
Metadata
Show full item record
Abstract
Background: Glioblastoma (GBM) develops resistance to the advances in chemotherapy leading to poor prognosis and life quality. Consequently, new treatment modalities are needed. Our aims were to investigate the effects of combined noscapine (NOS) and imat
URI
https://doi.org/10.1186/1475-2867-11-18
http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2136
Collections